Iravani, Mahmoud M <br/><br/>
3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Oct 2003 
 - 9107-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Behavior, Animal--drug effects<br/>Callithrix<br/>Disease Models, Animal<br/>Dopamine Agonists--pharmacology<br/>Dose-Response Relationship, Drug<br/>Dyskinesia, Drug-Induced--etiology<br/>Female<br/>Levodopa--adverse effects<br/>Male<br/>Motor Activity--drug effects<br/>N-Methyl-3,4-methylenedioxyamphetamine--therapeutic use<br/>Parkinsonian Disorders--chemically induced<br/>Receptor, Serotonin, 5-HT1B<br/>Receptors, Serotonin--drug effects<br/>Receptors, Serotonin, 5-HT1<br/>Serotonin Antagonists--pharmacology<br/>Serotonin Receptor Agonists--pharmacology<br/>Selective Serotonin Reuptake Inhibitors--pharmacology